Audit of the prescription of antimicrobials using the four moments of decision tool in a university hospital.

IF 5.2 2区 医学 Q1 INFECTIOUS DISEASES
Amanda Magalhães Vilas Boas Cambiais, Vanusa Barbosa Pinto, Andréa Cassia Pereira Sforsin, Luiz Marcelo Sa Malbouisson, Arnaldo Lichtenstein, Nelson De Luccia, Aleia Faustina Campos, Ícaro Boszczowski, Silvia Figueiredo Costa, Thaís Guimarães
{"title":"Audit of the prescription of antimicrobials using the four moments of decision tool in a university hospital.","authors":"Amanda Magalhães Vilas Boas Cambiais, Vanusa Barbosa Pinto, Andréa Cassia Pereira Sforsin, Luiz Marcelo Sa Malbouisson, Arnaldo Lichtenstein, Nelson De Luccia, Aleia Faustina Campos, Ícaro Boszczowski, Silvia Figueiredo Costa, Thaís Guimarães","doi":"10.1186/s13756-026-01761-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance is a growing global threat driven by inappropriate antimicrobial use. The Four Moments of Antibiotic Decision Making is a stewardship framework that promotes rational antibiotic use. This study applied this framework to audit antimicrobial prescribing, assess adherence, and measure antimicrobial use.</p><p><strong>Methods: </strong>We conducted a retrospective, cross-sectional audit of patients who received systemic antimicrobials between October and November 2023. The four audited moments included: (1) indication, suspected site, and clinical evidence of infection; (2) antimicrobial selection and culture collection; (3) reassessment between days 3 and 5 based on clinical response and culture results; and (4) treatment duration. Antimicrobial consumption was measured using days of therapy (DOT), length of therapy (LOT) and the WHO AWaRe classification.</p><p><strong>Results: </strong>A total of 228 patients (53.5% male; mean age 57 years) received 304 antimicrobial treatments, including 129 intensive care units (ICU) admissions. 75.0% were fully adherent to all Four Moments. Adherence rates across moments 1 to 4 were 97%, 88.8%, 89.3%, and 87.1%, respectively. In moment 2, cultures were indicated in 201 treatments but not requested in 15% of cases. Vancomycin was the most prolonged treatment, followed by ceftriaxone, piperacillin-tazobactam, and meropenem. Antimicrobial use was higher in ICUs, with DOT and LOT reaching 739 and 706 per 1,000 patient-days, respectively, compared with 496 and 319 in the wards. Most antimicrobial consumption corresponded to WHO AWaRe Watch antibiotics.</p><p><strong>Conclusions: </strong>Adherence to stewardship principles was high, although opportunities for improvement remain, particularly regarding culture collection and treatment duration optimization.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13488170/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Resistance and Infection Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13756-026-01761-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antimicrobial resistance is a growing global threat driven by inappropriate antimicrobial use. The Four Moments of Antibiotic Decision Making is a stewardship framework that promotes rational antibiotic use. This study applied this framework to audit antimicrobial prescribing, assess adherence, and measure antimicrobial use.

Methods: We conducted a retrospective, cross-sectional audit of patients who received systemic antimicrobials between October and November 2023. The four audited moments included: (1) indication, suspected site, and clinical evidence of infection; (2) antimicrobial selection and culture collection; (3) reassessment between days 3 and 5 based on clinical response and culture results; and (4) treatment duration. Antimicrobial consumption was measured using days of therapy (DOT), length of therapy (LOT) and the WHO AWaRe classification.

Results: A total of 228 patients (53.5% male; mean age 57 years) received 304 antimicrobial treatments, including 129 intensive care units (ICU) admissions. 75.0% were fully adherent to all Four Moments. Adherence rates across moments 1 to 4 were 97%, 88.8%, 89.3%, and 87.1%, respectively. In moment 2, cultures were indicated in 201 treatments but not requested in 15% of cases. Vancomycin was the most prolonged treatment, followed by ceftriaxone, piperacillin-tazobactam, and meropenem. Antimicrobial use was higher in ICUs, with DOT and LOT reaching 739 and 706 per 1,000 patient-days, respectively, compared with 496 and 319 in the wards. Most antimicrobial consumption corresponded to WHO AWaRe Watch antibiotics.

Conclusions: Adherence to stewardship principles was high, although opportunities for improvement remain, particularly regarding culture collection and treatment duration optimization.

利用四时刻决策工具对某高校医院抗菌药处方进行审核。
背景:抗菌素耐药性是由不适当使用抗菌素造成的日益严重的全球威胁。抗生素决策的四个时刻是一个促进合理使用抗生素的管理框架。本研究将该框架应用于审核抗菌素处方、评估依从性和测量抗菌素使用。方法:我们对2023年10月至11月接受全身性抗菌素治疗的患者进行了回顾性横断面审计。审核的四个时刻包括:(1)适应证、疑似部位和临床感染证据;(2)抗菌筛选和培养收集;(3)根据临床反应和培养结果,在第3天至第5天进行重新评估;(4)治疗时间。使用治疗天数(DOT)、治疗时间(LOT)和WHO AWaRe分类来测量抗菌药物的消耗。结果:228例患者(男性53.5%,平均年龄57岁)共接受304次抗菌药物治疗,其中129例入住重症监护病房(ICU)。75.0%的患者完全遵守所有四个时刻。第1至第4时刻的依从率分别为97%、88.8%、89.3%和87.1%。在第2时刻,201例治疗需要培养,但15%的病例不需要培养。万古霉素治疗时间最长,其次是头孢曲松、哌拉西林-他唑巴坦和美罗培南。icu的抗菌药物使用率较高,DOT和LOT分别达到739和706 / 1000患者日,而病房为496和319 / 1000患者日。大多数抗菌素消费符合世卫组织AWaRe Watch抗生素。结论:对管理原则的依从性很高,尽管仍有改进的机会,特别是在培养物收集和治疗时间优化方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.60%
发文量
140
审稿时长
13 weeks
期刊介绍: Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. The journal covers a broad spectrum of preeminent practices and best available data to the top interventional and translational research, and innovative developments in the field of infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书